-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Health Yuan (600380.SH) issued an announcement. Recently, Lizhu Group Lizhu Pharmaceutical Factory (abbreviation: Lizhu Pharmaceutical Factory), a holding subsidiary of the company's holding subsidiary, has received the approval and issuance of the “Drug Clinical Trial Approval Notice” (Notice No.: 2025LP03436, 2025LP03437) of NS-041 tablets for “treatment of depression”, and agreed to conduct clinical trials with NS-041 tablets for additional indications.

Zhitongcaijing·12/21/2025 07:57:03
Listen to the news
Zhitong Finance App News, Health Yuan (600380.SH) issued an announcement. Recently, Lizhu Group Lizhu Pharmaceutical Factory (abbreviation: Lizhu Pharmaceutical Factory), a holding subsidiary of the company's holding subsidiary, has received the approval and issuance of the “Drug Clinical Trial Approval Notice” (Notice No.: 2025LP03436, 2025LP03437) of NS-041 tablets for “treatment of depression”, and agreed to conduct clinical trials with NS-041 tablets for additional indications.